Researchers urge use of two drugs to prevent HIV transmission

08/4/2008 | Financial Times (free content)

Leading AIDS researchers, backed by the the AIDS Vaccine Advocacy Coalition, called for increased funding to study widespread use of Gilead Sciences' HIV drugs tenofovir and emtricitabine as preventive therapy for those at high risk of the disease. The recommendation came after several setbacks in recent studies aimed at discovering vaccines against HIV infection.

View Full Article in:

Financial Times (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC